Britain Faces Looming Medicine Shortages as Iran Conflict Escalates
The war involving Iran is creating a “perfect storm” that threatens to disrupt the UK’s medicine supply, potentially leading to shortages of vital drugs – from common painkillers to critical cancer treatments – within weeks. The closure of much of the Strait of Hormuz and disruption to Gulf air routes are choking supplies of key raw materials, including those needed for pharmaceutical production.
The Fragile Supply Chain: A Global Interdependence
The UK relies heavily on a complex global supply chain for its medicines. Approximately half of all medicines are produced domestically, with a third sourced from India and the remainder largely from the EU. India, often referred to as the “pharmacy of the world,” provides around 60% of the generic medicines used globally and a significant portion of those consumed in the UK. This reliance makes the UK particularly vulnerable to disruptions in Indian production and export.
Air and Sea Routes Under Strain
The conflict has severely impacted both air and sea freight. Airports in Dubai, Doha, and Abu Dhabi have faced closures and limited schedules, forcing rerouting of shipments and causing an 80% plunge in air cargo through the region earlier this month. Approximately one in five NHS medicines, including expensive cancer drugs and time-sensitive therapies, arrive by air. Sea shipping, the primary route for most medicines, is facing major strain due to the near-total closure of the Strait of Hormuz, adding 14 days and approximately £750,000 in extra fuel costs per voyage if ships are rerouted around the Cape of Good Hope.
Rising Costs and Margin Squeeze
The war has already doubled air freight costs, and manufacturers are currently absorbing these increases. However, historically low margins within the pharmaceutical industry mean that some drugs could grow unprofitable for the NHS. While long-term contracts limit price increases for hospitals, suppliers can increase costs for GP practices and pharmacies. Experts anticipate single-digit price increases if the conflict worsens.
Impact on Active Pharmaceutical Ingredients (APIs)
Beyond finished medicines, the conflict is also impacting the supply of Active Pharmaceutical Ingredients (APIs) – the raw materials used to manufacture drugs. Rising oil and gas prices are inflating the costs of petrochemicals like methanol and ethylene, which are essential components of many APIs and medical equipment, such as syringes and vials. This ripple effect is expected to translate into higher costs for patients and taxpayers.
Echoes of Past Shortages
The current situation evokes memories of the COVID-19 pandemic, when the UK experienced shortages of paracetamol and other painkillers due to disruptions in Indian production. While healthcare cargo currently retains priority over e-commerce, prolonged disruption could threaten even the stable supply of generic medications.
What Does This Mean for Patients?
Currently, the UK is not in a crisis situation, but buffer stocks are being closely monitored. Medical distributors typically hold six to eight weeks of stock, while hospital suppliers in England maintain eight weeks’ worth. However, the clock is ticking, and widespread shortfalls could materialize if the conflict continues. The potential consequences include delays in treatment, rationing of medications, and increased pressure on healthcare professionals.
Did you realize?
Generics account for 85% of all medications prescribed by the NHS, making the UK particularly vulnerable to disruptions in the generic drug supply chain.
FAQ: Medicine Shortages and the Iran Conflict
- How long before we see shortages? Shortages could begin to appear within a few weeks if the conflict continues.
- Which medicines are most at risk? Medicines arriving by air, such as cancer drugs and infectious disease treatments, are particularly vulnerable.
- Is the UK government taking action? The UK is working with allies on a collective plan to reopen the Strait of Hormuz and restore freedom of navigation.
- Will the NHS be able to cope? The NHS is monitoring buffer stocks closely, but prolonged disruption could overwhelm the system.
Pro Tip: Stay informed about potential medicine shortages by checking the NHS website and consulting with your doctor or pharmacist.
To learn more about supply chain resilience and the pharmaceutical industry, explore resources from Pharma.Aero and Moody’s Analytics.
What are your thoughts on this developing situation? Share your concerns and experiences in the comments below.
